← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cleveland Biolabs, Inc.
Buffalo, NY
$9,533,966
Total funding
10
Grants
Funding over time
peak $3.3M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$9,312,281 · 9
DOD$221,685 · 1
By mechanism
RC2$5,329,543 · 1
R01$1,500,000 · 1
RC1$1,232,695 · 1
R44$750,305 · 1
R43$399,748 · 4
—$221,685 · 1
Investigators at Cleveland Biolabs, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Mechanisms of mitigation of radiation damage of GI tract by Protectan CBLB502$2,844,359
RC2 · FY2009 · AI
Mechanisms of mitigation of radiation damage of GI tract by Protectan CBLB502$2,485,184
RC2 · FY2010 · AI
Protecting immune system by modulators of p53 and NF-kB$1,500,000
R01 · FY2005 · AI
Protectan CBLB502$774,183
RC1 · FY2008 · AI
Protectan CBLB502$458,512
RC1 · FY2009 · AI
N-myc Targeted Therapeutics for Childhood Neuroblastoma$396,999
R44 · FY2007 · CA
N-myc Targeted Therapeutics for Childhood Neuroblastoma$353,306
R44 · FY2006 · CA
ENTOLIMOD: A MEDICAL COUNTERMEASURE TO REDUCE THE RISK OF DEATH FOLLOWING RADIATION EXPOSURE$221,685
· FY2015 · Department of the Army
Bacterial Proteins as Cancer Drugs and Radioprotectors$100,000
R43 · FY2005 · CA
New approach to improve abdominopelvic radiotherapy by protecting small intestine$100,000
R43 · FY2005 · CA
Effective Radioprotectants Targeting Toll-like Receptor 5$100,000
R43 · FY2005 · CA
Development of new inhibitors of androgen receptors$99,990
R41 · FY2004 · CA
N-myc Targeted Therapeutics for Childhood Neuroblastoma$99,748
R43 · FY2004 · CA